A Development Journey: Navigating the Challenges & Opportunities in Medical Interventions
Time: 8:30 am
day: Conf Day 1
Details:
- Applying medications to life-threatening disease in premature infants including NEC and sepsis
- Considering product quality for a highly vulnerable patient population with the ambition for IBP-9414 to become the world’s first approved medication for premature infants
- Examining the data from the largest randomized controlled trial in the premature infants ever
